PubMed:568514
Annnotations
GlyCosmos15-Species
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 2 | 30-63 | Species | denotes | Bandeiraea simplicifolia lectin I | |
| 37 | 204-237 | Species | denotes | Bandeiraea simplicifolia lectin I | |
| 38 | 239-243 | Species | denotes | BS I | |
| 40 | 320-325 | Species | denotes | human | 9606 |
| 42 | 420-425 | Species | denotes | human | 9606 |
| 46 | 563-568 | Species | denotes | human | 9606 |
| 52 | 816-821 | Species | denotes | human | 9606 |
| 53 | 851-856 | Species | denotes | human | 9606 |
| 67 | 1735-1739 | Species | denotes | BS I |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 130-143 | Glycan_Motif | denotes | blood-group A | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G58507AZ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G17108EX |
| T3 | 350-363 | Glycan_Motif | denotes | Blood-group B | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G65112QB|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G60395SO|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G41865GQ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G26934CO|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00067MO |
| T8 | 498-511 | Glycan_Motif | denotes | blood-group B | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G65112QB|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G60395SO|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G41865GQ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G26934CO|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00067MO |
| T13 | 569-582 | Glycan_Motif | denotes | blood-group A | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G58507AZ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G17108EX |
| T15 | 822-835 | Glycan_Motif | denotes | blood-group B | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G65112QB|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G60395SO|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G41865GQ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G26934CO|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00067MO |
| T20 | 857-870 | Glycan_Motif | denotes | blood-group A | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G58507AZ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G17108EX |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 98-103 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T2 | 98-103 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T3 | 130-135 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T4 | 130-135 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T5 | 350-355 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | Blood |
| T6 | 350-355 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | Blood |
| T7 | 498-503 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T8 | 498-503 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T9 | 569-574 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T10 | 569-574 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T11 | 599-605 | http://purl.obolibrary.org/obo/MAT_0000444 | denotes | saliva |
| T12 | 645-650 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T13 | 645-650 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T14 | 822-827 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T15 | 822-827 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
| T16 | 857-862 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T17 | 857-862 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-184 | Sentence | denotes | A study of the specificity of Bandeiraea simplicifolia lectin I by competitive-binding assay with blood-group substances and with blood-group A and B active and other oligosaccharides. |
| TextSentencer_T2 | 185-349 | Sentence | denotes | The specificity of Bandeiraea simplicifolia lectin I (BS I) has been studied by competitive-binding assays (CBA) using tritium-labeled human B and hog A substances. |
| TextSentencer_T3 | 350-629 | Sentence | denotes | Blood-group B substances isolated from horse gastric mucosae and from human ovarian-cyst fluids were much better inhibitors of binding of tritiated blood-group B substance to insoluble BS I-Sepharose 2B than were human blood-group A substances from saliva and ovarian-cyst fluid. |
| TextSentencer_T4 | 630-779 | Sentence | denotes | A and B active blood-group substances showed the same range of potency in inhibiting binding of tritium-labeled hog A substance to BS I-Sepharose 2B. |
| TextSentencer_T5 | 780-958 | Sentence | denotes | CBA with BS I-Sepharose 2B, labeled human blood-group B substance, and human blood-group A and B active aligosaccharides separated the haptens into two groups differing in slope. |
| TextSentencer_T6 | 959-1411 | Sentence | denotes | Group 1, containing methyl alpha-D-GalNAcp, D-GalNAcp, and an A active pentasaccharide ARL 0.52, with 3, 19, and 25 nmol respectively needed for 50% inhibition of binding, has a lower slope than group 2, which contains alpha-D-GalNAcp-(1 leads to 3)-2-acetamido-2-deoxy-D-galactitol and p-nitrophenyl alpha-D-GalNAcp, with 3 nmol of each required for 50% inhibition of binding, as well as ten glycosides with terminal, nonreducing, alpha-linked D-Galp. |
| TextSentencer_T7 | 1412-1659 | Sentence | denotes | The most potent inhibitors of this group were p-nitrophenyl alpha-D-Galp, alpha-D-Galp-(1 leads to 3)-D-Galp, alpha-D-Galp-(1 leads to 6)-D-Glcp, and methyl alpha-D-Galp, with 5, 7.4, 9.6, and 11 nmol respectively needed to inhibit binding by 50%. |
| TextSentencer_T8 | 1660-2073 | Sentence | denotes | The difference in slopes was explainable in terms of a recent finding that BS I exists as a mixture of five isolectins composed of two subunits having different specificities; subunit A is most specific for alpha-linked, terminal, nonreducing D-GalNAcp, but it also reacts with alpha-linked, terminal, nonreducing D-Galp, whereas subunit B tends to be more specific for terminal, nonreducing, alpha-linked D-Galp. |
| T1 | 0-184 | Sentence | denotes | A study of the specificity of Bandeiraea simplicifolia lectin I by competitive-binding assay with blood-group substances and with blood-group A and B active and other oligosaccharides. |
| T2 | 185-349 | Sentence | denotes | The specificity of Bandeiraea simplicifolia lectin I (BS I) has been studied by competitive-binding assays (CBA) using tritium-labeled human B and hog A substances. |
| T3 | 350-629 | Sentence | denotes | Blood-group B substances isolated from horse gastric mucosae and from human ovarian-cyst fluids were much better inhibitors of binding of tritiated blood-group B substance to insoluble BS I-Sepharose 2B than were human blood-group A substances from saliva and ovarian-cyst fluid. |
| T4 | 630-779 | Sentence | denotes | A and B active blood-group substances showed the same range of potency in inhibiting binding of tritium-labeled hog A substance to BS I-Sepharose 2B. |
| T5 | 780-958 | Sentence | denotes | CBA with BS I-Sepharose 2B, labeled human blood-group B substance, and human blood-group A and B active aligosaccharides separated the haptens into two groups differing in slope. |
| T6 | 959-1411 | Sentence | denotes | Group 1, containing methyl alpha-D-GalNAcp, D-GalNAcp, and an A active pentasaccharide ARL 0.52, with 3, 19, and 25 nmol respectively needed for 50% inhibition of binding, has a lower slope than group 2, which contains alpha-D-GalNAcp-(1 leads to 3)-2-acetamido-2-deoxy-D-galactitol and p-nitrophenyl alpha-D-GalNAcp, with 3 nmol of each required for 50% inhibition of binding, as well as ten glycosides with terminal, nonreducing, alpha-linked D-Galp. |
| T7 | 1412-1659 | Sentence | denotes | The most potent inhibitors of this group were p-nitrophenyl alpha-D-Galp, alpha-D-Galp-(1 leads to 3)-D-Galp, alpha-D-Galp-(1 leads to 6)-D-Glcp, and methyl alpha-D-Galp, with 5, 7.4, 9.6, and 11 nmol respectively needed to inhibit binding by 50%. |
| T8 | 1660-2073 | Sentence | denotes | The difference in slopes was explainable in terms of a recent finding that BS I exists as a mixture of five isolectins composed of two subunits having different specificities; subunit A is most specific for alpha-linked, terminal, nonreducing D-GalNAcp, but it also reacts with alpha-linked, terminal, nonreducing D-Galp, whereas subunit B tends to be more specific for terminal, nonreducing, alpha-linked D-Galp. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 130-143 | https://glytoucan.org/Structures/Glycans/G17108EX | denotes | blood-group A |
| T2 | 130-143 | https://glytoucan.org/Structures/Glycans/G58507AZ | denotes | blood-group A |
| T3 | 350-363 | https://glytoucan.org/Structures/Glycans/G00067MO | denotes | Blood-group B |
| T4 | 350-363 | https://glytoucan.org/Structures/Glycans/G26934CO | denotes | Blood-group B |
| T5 | 350-363 | https://glytoucan.org/Structures/Glycans/G41865GQ | denotes | Blood-group B |
| T6 | 350-363 | https://glytoucan.org/Structures/Glycans/G60395SO | denotes | Blood-group B |
| T7 | 350-363 | https://glytoucan.org/Structures/Glycans/G65112QB | denotes | Blood-group B |
| T8 | 498-511 | https://glytoucan.org/Structures/Glycans/G00067MO | denotes | blood-group B |
| T9 | 498-511 | https://glytoucan.org/Structures/Glycans/G26934CO | denotes | blood-group B |
| T10 | 498-511 | https://glytoucan.org/Structures/Glycans/G41865GQ | denotes | blood-group B |
| T11 | 498-511 | https://glytoucan.org/Structures/Glycans/G60395SO | denotes | blood-group B |
| T12 | 498-511 | https://glytoucan.org/Structures/Glycans/G65112QB | denotes | blood-group B |
| T13 | 569-582 | https://glytoucan.org/Structures/Glycans/G17108EX | denotes | blood-group A |
| T14 | 569-582 | https://glytoucan.org/Structures/Glycans/G58507AZ | denotes | blood-group A |
| T15 | 822-835 | https://glytoucan.org/Structures/Glycans/G00067MO | denotes | blood-group B |
| T16 | 822-835 | https://glytoucan.org/Structures/Glycans/G26934CO | denotes | blood-group B |
| T17 | 822-835 | https://glytoucan.org/Structures/Glycans/G41865GQ | denotes | blood-group B |
| T18 | 822-835 | https://glytoucan.org/Structures/Glycans/G60395SO | denotes | blood-group B |
| T19 | 822-835 | https://glytoucan.org/Structures/Glycans/G65112QB | denotes | blood-group B |
| T20 | 857-870 | https://glytoucan.org/Structures/Glycans/G17108EX | denotes | blood-group A |
| T21 | 857-870 | https://glytoucan.org/Structures/Glycans/G58507AZ | denotes | blood-group A |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 130-143 | Glycan | denotes | blood-group A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00066MO |
| T2 | 569-582 | Glycan | denotes | blood-group A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00066MO |
| T3 | 857-870 | Glycan | denotes | blood-group A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00066MO |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 239-243 | Disease | denotes | BS I | http://purl.obolibrary.org/obo/MONDO_0015085 |
| T2 | 332-337 | Disease | denotes | hog A | http://purl.obolibrary.org/obo/MONDO_0009796 |
| T3 | 426-438 | Disease | denotes | ovarian-cyst | http://purl.obolibrary.org/obo/MONDO_0003282 |
| T4 | 535-539 | Disease | denotes | BS I | http://purl.obolibrary.org/obo/MONDO_0015085 |
| T5 | 610-622 | Disease | denotes | ovarian-cyst | http://purl.obolibrary.org/obo/MONDO_0003282 |
| T6 | 742-747 | Disease | denotes | hog A | http://purl.obolibrary.org/obo/MONDO_0009796 |
| T7 | 761-765 | Disease | denotes | BS I | http://purl.obolibrary.org/obo/MONDO_0015085 |
| T8 | 789-793 | Disease | denotes | BS I | http://purl.obolibrary.org/obo/MONDO_0015085 |
| T9 | 1735-1739 | Disease | denotes | BS I | http://purl.obolibrary.org/obo/MONDO_0015085 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 426-438 | Phenotype | denotes | ovarian-cyst | HP:0000138 |
| T2 | 610-622 | Phenotype | denotes | ovarian-cyst | HP:0000138 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 426-438 | Phenotype | denotes | ovarian-cyst | HP:0000138 |
| T2 | 610-622 | Phenotype | denotes | ovarian-cyst | HP:0000138 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-184 | Sentence | denotes | A study of the specificity of Bandeiraea simplicifolia lectin I by competitive-binding assay with blood-group substances and with blood-group A and B active and other oligosaccharides. |
| T2 | 185-349 | Sentence | denotes | The specificity of Bandeiraea simplicifolia lectin I (BS I) has been studied by competitive-binding assays (CBA) using tritium-labeled human B and hog A substances. |
| T3 | 350-629 | Sentence | denotes | Blood-group B substances isolated from horse gastric mucosae and from human ovarian-cyst fluids were much better inhibitors of binding of tritiated blood-group B substance to insoluble BS I-Sepharose 2B than were human blood-group A substances from saliva and ovarian-cyst fluid. |
| T4 | 630-779 | Sentence | denotes | A and B active blood-group substances showed the same range of potency in inhibiting binding of tritium-labeled hog A substance to BS I-Sepharose 2B. |
| T5 | 780-958 | Sentence | denotes | CBA with BS I-Sepharose 2B, labeled human blood-group B substance, and human blood-group A and B active aligosaccharides separated the haptens into two groups differing in slope. |
| T6 | 959-1659 | Sentence | denotes | Group 1, containing methyl alpha-D-GalNAcp, D-GalNAcp, and an A active pentasaccharide ARL 0.52, with 3, 19, and 25 nmol respectively needed for 50% inhibition of binding, has a lower slope than group 2, which contains alpha-D-GalNAcp-(1 leads to 3)-2-acetamido-2-deoxy-D-galactitol and p-nitrophenyl alpha-D-GalNAcp, with 3 nmol of each required for 50% inhibition of binding, as well as ten glycosides with terminal, nonreducing, alpha-linked D-Galp. The most potent inhibitors of this group were p-nitrophenyl alpha-D-Galp, alpha-D-Galp-(1 leads to 3)-D-Galp, alpha-D-Galp-(1 leads to 6)-D-Glcp, and methyl alpha-D-Galp, with 5, 7.4, 9.6, and 11 nmol respectively needed to inhibit binding by 50%. |
| T7 | 1660-2073 | Sentence | denotes | The difference in slopes was explainable in terms of a recent finding that BS I exists as a mixture of five isolectins composed of two subunits having different specificities; subunit A is most specific for alpha-linked, terminal, nonreducing D-GalNAcp, but it also reacts with alpha-linked, terminal, nonreducing D-Galp, whereas subunit B tends to be more specific for terminal, nonreducing, alpha-linked D-Galp. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 426-438 | Disease | denotes | ovarian-cyst | MONDO:0003282 |
| T2 | 610-622 | Disease | denotes | ovarian-cyst | MONDO:0003282 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 320-325 | OrganismTaxon | denotes | human | 9606 |
| T2 | 420-425 | OrganismTaxon | denotes | human | 9606 |
| T3 | 563-568 | OrganismTaxon | denotes | human | 9606 |
| T4 | 816-821 | OrganismTaxon | denotes | human | 9606 |
| T5 | 851-856 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 98-103 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T2 | 130-135 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T3 | 350-355 | Body_part | denotes | Blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T4 | 395-410 | Body_part | denotes | gastric mucosae | http://purl.obolibrary.org/obo/UBERON_0001199 |
| T5 | 498-503 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T6 | 569-574 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T7 | 599-605 | Body_part | denotes | saliva | http://purl.obolibrary.org/obo/UBERON_0001836 |
| T8 | 623-628 | Body_part | denotes | fluid | http://purl.obolibrary.org/obo/UBERON_0006314 |
| T9 | 645-650 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T10 | 822-827 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T11 | 857-862 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 98-103 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T3 | 130-135 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T5 | 350-355 | Body_part | denotes | Blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T7 | 498-503 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T9 | 569-574 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T11 | 599-605 | Body_part | denotes | saliva | http://purl.obolibrary.org/obo/MAT_0000444 |
| T12 | 645-650 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T14 | 822-827 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
| T16 | 857-862 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |